Research of Big Biotech Deals and Alliances : Technology, Applications, Growth and Status 2017
Researchmoz added Most up-to-date research on "Big Biotech Deals and Alliances of 2014" to its huge collection of research reports.
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of 2014 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=256050
Table of Content
Executive Summary
Chapter 1 – Trends in dealmaking during 2014
1.1. Big biotech dealmaking activity
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area
Chapter 2 – Leading deals during 2014
2.1. Introduction
2.2. Top deals by value during 2012
Chapter 3 – Big biotech deals during 2014
3.1. Introduction
3.2. How to use big biotech partnering deals
3.3. Big biotech partnering company profiles for 2014
Roche
Teva Pharmaceuticals
Amgen
Novo Nordisk
Merck KGaA
Gilead Sciences
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication.
Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big biotech companies with a brief summary followed by a comprehensive listing of 2014 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=256050
Table of Content
Executive Summary
Chapter 1 – Trends in dealmaking during 2014
1.1. Big biotech dealmaking activity
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area
Chapter 2 – Leading deals during 2014
2.1. Introduction
2.2. Top deals by value during 2012
Chapter 3 – Big biotech deals during 2014
3.1. Introduction
3.2. How to use big biotech partnering deals
3.3. Big biotech partnering company profiles for 2014
Roche
Teva Pharmaceuticals
Amgen
Novo Nordisk
Merck KGaA
Gilead Sciences
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/
Comments
Post a Comment